High-Dose Lanreotide in the Treatment of Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: A Case Report

Pancreatic neuroendocrine tumors (NETs), including poorly differentiated carcinomas (NECs), are rarely encountered. The majority of these tumors do not secrete excess hormones, but functioning NETs produce large amounts of vasoactive peptides and may cause carcinoid syndrome. Synthetic somatostatin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Van Fraeyenhove, Frank, Meireson, Nathalie, Terriere, Luc, Willemsen, Paul, Kunnen, Jan, Mattelaer, Caroline, Van Acker, Frank, Schrijvers, Dirk
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2014
Assuntos:
Published online: March, 2014
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3975754/
https://ncbi.nlm.nih.gov/pubmed/24707264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000360732
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados